Check out what @DanielMaMD has to say about his RCT of DART for HPV associated oropharynx cancer. Is de-escalation ready for prime time? You want to know what he says. It was fun, and he has some incredible insight! @QuadShotNews@ASTRO_org#ASTRO21
https://t.co/C936EDaXuu
It was awesome to chat with David Palma about ORATOR2, de-escalation in HPV associated oropharynx cancer treatment, and oligomet treatment. @QuadShotNews@ASTRO_org#ASTRO21. https://t.co/c4bwioEijO
Excited that we were able to offer the first adaptive treatments on the @Varian Ethos platform for our @uabmedicine patients this week. Exciting times are here. Thanks @DennisNStanley and team!
It was awesome chatting with @CancerConnector and learning more about RSI and GARD. For a deeper dive check out our @QuadShotNews podcast episode to learn more. #RadOnc https://t.co/OY3ByI3dHO
Thanks @QuadShotNews for highlighting our @TheLancetOncol paper - and for distilling the nitty gritty of GARD in terms of personalized BED. Clear, concise #radonc teaching!
paper: https://t.co/3crLxn8VEP
QuadShot: https://t.co/ETiEPPoACL
#clecliniccancer@CCLRI@CWRUSOM
@ChelainG@ShaunaRadOnc@EJeansMD@S_Dooley7@ChelainG is the most thorough editor / co-author I’ve ever known - although the edits/changes can be what a radiologist would consider “innumerable” - the final product is always better. Keep doing your thing!
The QuadCast is evolving to take deeper dives into (1) the most awesome emerging advancements in our field and (2) the people making it happen.
Take a listen to our interview with @CancerConnector and @jtorresroca whose team is bringing personalized med to rad onc.
Excited for @kmelt_1 to join the team @UABradonc. 🎉🎉Maybe he will be the key to us winning the annual meeting 5k - assuming we have those in person one day 🤷🏻♂️
I love podcasts and this one is especially pertinent and such a good listen! Check it out and continue your oncology learning when you are driving or at the gym! @QuadShotNews @SamuelMarcromMD https://t.co/uQvUUy0uq5